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Autophagy requires poly(adp-ribosyl)ation-dependent
AMPK nuclear export
José M Rodríguez-Vargas1, María I Rodríguez1,5, Jara Majuelos-Melguizo1,5, Ángel García-Diaz1, Ariannys González-Flores1,
Abelardo López-Rivas2, László Virág3, Giuditta Illuzzi4, Valerie Schreiber4, Françoise Dantzer4 and FJavier Oliver*,1
AMPK is a central energy sensor linking extracellular milieu fluctuations with the autophagic machinery. In the current study we
uncover that Poly(ADP-ribosyl)ation (PARylation), a post-translational modification (PTM) of proteins, accounts for the spatial and
temporal regulation of autophagy by modulating AMPK subcellular localisation and activation. More particularly, we show that the
minority AMPK pool needs to be exported to the cytosol in a PARylation-dependent manner for optimal induction of autophagy,
including ULK1 phosphorylation and mTORC1 inactivation. PARP-1 forms a molecular complex with AMPK in the nucleus in non-
starved cells. In response to nutrient deprivation, PARP-1 catalysed PARylation, induced the dissociation of the PARP-1/AMPK
complex and the export of free PARylated nuclear AMPK to the cytoplasm to activate autophagy. PARP inhibition, its silencing or
the expression of PARylation-deficient AMPK mutants prevented not only the AMPK nuclear-cytosolic export but also affected the
activation of the cytosolic AMPK pool and autophagosome formation. These results demonstrate that PARylation of AMPK is a key
early signal to efficiently convey extracellular nutrient perturbations with downstream events needed for the cell to optimize
autophagic commitment before autophagosome formation.
Cell Death and Differentiation advance online publication, 30 September 2016; doi:10.1038/cdd.2016.80
Macroautophagy (hereafter called autophagy) is an evolutio-
narily conserved pathway involving the formation of a double-
membrane vesicle, the autophagosome, which engulfs
cytoplasmic components and delivers them to the lysosome
for degradation.1 Autophagy is also a major mechanism by
which starved cells reallocate nutrients from non-vital path-
ways to more essential processes2 and its disruption is
associated with multiple disease states, including neuro-
degenerative diseases, cancer, infection, and several
myopathies.3–5
The intracellular mechanisms that spatially and temporally
fine-tune the initiation of autophagy still remain poorly under-
stood. Poly(ADP-ribose) polymerase-1 (PARP-1) catalyzes
the conversion of NAD+ to polymers of Poly(ADP-ribose)
(PAR) in a process called PARylation which plays different
pleiotropic cellular roles ranging from DNA damage sensing to
transcription, chromatin relaxation or cell death.6 We have
recently shown that during starvation-induced autophagy
PARP-1 activation is involved in amplifying autophagy by
feeding-back ROS production/DNA damage/NAD+consump-
tion axis.7 In the present study we uncover a new and
unexpected role for PARylation in the early signalling of
autophagy: PARP-1 activation leads to AMPK PARylation,
dissociation of PARP-1-AMPK complex and the nuclear-to-
cytosolic export of AMPK, an event needed to induce
mTORC1 inactivation/ULK1 phosphorylation in the cytosol.
Together, these findings identify a new regulatory mechanism
in autophagy and expand the known functions of AMPK and
PARP-1 to include spatial regulation of the early signals of
autophagy in mammalian cells.
Results
PARylation regulates starvation-induced autophagy. To
analyze the importance of PARylation in starvation-induced
autophagy we used the breast cancer cell line MCF7 cells
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stably transfected with GFPLC3. PARP-1 is the best studied
member of the PARP protein family accounting for around
90% of cellular PARylation activity following different
stimuli.8,9 Recent studies have demonstrated its involvement
in the regulation of DNA damage- or starvation-induced
autophagy.10,11
To correlate PARproductionwith starvation, we used thePARP
inhibitors PJ34, DPQ and olaparib, iPARP-1 and iPARG (Poly
(ADP-ribose)glycohydrolase) (Figure 1a, Supplementary Figure
S1a, b and c; the efficiency of iPARP-1 and iPARG are shown in
Figure 1a and Supplementary Figure S1c). Supplementary
Figure S1a show that starvation induced PAR synthesis and in
iPARP cells or after treatment with different PARP inhibitors
autophagy was reduced (Figure 1a, Supplementary Figure S1b).
In contrast in PARG-depleted cells, the accumulation of PAR
accelerated autophagy after nutrient deprivation (Figure 1a). It
has been reported that PAR accumulation may induce cell death
(called PARthanatos),12 however this was not the case as PAR
accumulation after nutrient deprivation did not compromise cell
viability (Supplementary Figure S1d). Thus, the increased level of
autophagy was not ascribed to a cellular attempt to detoxify
the excess of PAR in autophagosomes, but there may be a
mechanismof fine-tuning in the induction of PARylation-mediated
autophagy. Fluorescent microscopic images showed an
Figure 1 Poly(ADP-ribose) regulates autophagy during nutrient deprivation. (a) Effect of PARG silencing, PARP silencing and PARP inhibition on starvation-induced
autophagy. MCF7 GFPLC3 cells were transfected with PARP-1 siRNA (60 nM) or PARG siRNA (30 nM). 48 h later cells were starved with HANK Buffer. Other cells were pre-
treated with 10 μM PJ34 for 1.5 h and maintained during the nutrient deprivation. * Po0.05, **Po0.01, ***Po0.001 versus the indicated group in MCF7 GFPLC3 cells by t-test.
Western blot and qPCR for PARP-1 and PARG knock-down are shown. (b) Autophagy as active process dependent of PARylation levels. MCF7 GFPLC3 cells were transfected
with PARG siRNA (30 nM). 48 h later, 3-MA (5 mM) and Bafilomycin A1 (0.2 μM) were used as autophagy inhibitors during the starvation treatment. 10 μM PJ34 for 1.5 h and
maintained during the nutrient deprivation was used as PARylation inhibition control. * Po0.05, **Po0.01, ***Po0.001 versus the indicated group by t-test in MCF7 GFPLC3
cells. Lower panel shows endogenous LC3-II protein conversion during starvation, PARG siRNA or PJ34, alone or in co-treatment with 3-MA and Bafilomycin A1. α-tubulin was
used as loading control. (c) Effect of PAR accumulation on starvation-induced autophagy. ShVector and shPARG A549 cells were starved with HANK buffer. The right panel shows
the effect of PARPs inhibitor on the endogenous starvation-induced LC3-II conversion. α-tubulin was used as loading control. *Po0.05, **Po0.01 versus the indicated group in
shVector and shPARG A549 cells by t-test. (d) Effect of ULK1 silencing on starvation-induced autophagy. ShVector and shPARG A549 cells were transfected with ULK1 siRNA
(50 nM). 48 h later cells were starved with HANK buffer. The right panel shows the effect of ULK1 silencing on ULK1 protein levels and the endogenous starvation-induced LC3-II
conversion in shPARG A549 cells. α-tubulin was used as loading control *Po0.05, **Po0.01, ***Po0.001 versus the indicated group in shVector and shPARG A549 cells by
t-test. In all cases, at least 250 cells were counted in a Zeiss fluorescent microscope and data were represented as mean±S.E.M. of 3 independent experiments. In A, B and D
figures scrambled or non-specific siRNA was used as negative control
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increased accumulation of autophagosomes in siPARG cells
while inhibition of PARylation or PARP-1 knock-down abrogated
starvation-induced autophagy (Supplementary Figure S1e). To
analyze if PARylation-associated autophagy was an active
process, we studied the membrane traffic associated to nutrient
deprivation in presence of PARP inhibitors or PARG knock-down
in combination with the autophagy inhibitors 3-MA, Chloroquine
and Bafilomycin A1. Doses of autophagy inhibitors were
established in MCF7 GFPLC3 during nutrient deprivation
(Supplementary Figure S1f). By using the co-treatment of PARP
inhibitors or siPARG in combination with 3-MA and Bafilomycin
A1, we demonstrated that starvation-induced autophagy is an
active process dependent of PAR levels and PARP activity
(Figure 1b), as Bafilomycin A1 recovered the rate of autophagic
cells and increased LC3-II translocation in starved cells treated
with PJ34 or siPARG. To confirm the role of PAR in autophago-
some formation, we used A549 cells stably-depleted for PARG13
which showed increased starvation-associated PARylation.
Besides, PAR accumulation during nutrient deprivation did not
affect to cell survival (data not shown) and induced a rapid
translocation of LC3-II protein, compared with starved A549
shVector cells (Figure 1c and data not shown).
A549 shPARG cells accumulated more autophagosomes
compared with A549 shVector cells (Figures 1c and d and
Supplementary Figure S2a). To further evaluate the impact of
PAR, cells were treated with PJ34, which reduced the levels of
starvation-induced autophagy in parental and shPARG cells
(Figure 1c). Accordingly, LC3-II translocation in A549 shPARG
cells disappeared after PARP inhibition (Figure 1c). Next, we
evaluated the role of PAR synthesis in starvation-induced
autophagy after silencing ULK1 which blocked autophago-
some formation and LC3II translocation during starvation in
both A549 cell lines (Figure 1d). These results suggest a
dynamic interaction between PAR and the initiation of
autophagy. In addition, silencing of other ATG-related protein
as ATG7, confirmed the results obtained in starved A549
shPARG cells (Supplementary Figure S2b). All these data
indicated that starvation-induced PARylation is directly and
actively involved in autophagy formation.
Inhibition of PARylation down-regulates AMPKα activa-
tion and autophagy induction. The cellular metabolic
status is sensed by two essential proteins, AMPK as an
energetic sensor and mTORC1 complex as a nutritional
sensor.14–16 Under energy rich levels, active mTORC1 acts
as a negative regulator of autophagy, allowing proliferation
and cell growth. On the contrary, AMPK is activated under
energy depletion, and it is a positive regulator of autophagy,
through in part inhibiting mTORC1.17
In view of the connection between PAR synthesis and the
energy status of the cell we aimed to evaluate AMPK (hence
forth AMPKα) during nutrient deprivation; we firstly observed a
time-dependent decrease on ATP levels in MCF7 GFPLC3
cells following starvation (Supplementary Figure S3a, left
panel) which correlated with an increase in AMPKα activation
(Supplementary Figure S3a, right panel). Because PARP-1 is
activated during nutrient deprivation (Supplementary Figure
S1a), we hypothesized that the levels of PAR could regulate
AMPKα activation. In line with this result, both PJ34 treatment
or iPARP1 prevented starvation-induced ATP depletion
(Figure 2a), implying that over-activation of PARP-1 during
starvation was the main cause of energy drop in the starved
cells. In addition, PJ34 treatment and iPARP-1 recovered ATP
levels while AMPKα and autophagy were fully inactive
(Figure 1a and Figure 2b). PARG silencing had no effect on
ATP levels during starvation (Figures 2c and d). In starved
MCF7GFPLC3 cells, inhibition of autophagy in the initial steps
with 3-MA, totally abrogated the activation of AMPKα
(Supplementary Figure S3b); however there was no effect
on AMPK activation after combination with Bafilomycin A1
suggesting that PARylation was affecting early autophagy
events where ATP depletion and AMPK activation is taking
place. To confirm the functional link between PARP-1 and
AMPK,we used parp-1+/+ and parp-1−/−MEFs cells. parp-1−/−
cells displayed a significant down-regulation in AMPKα
activation during starvation (Figure 2e), and the percentage
of autophagic cells decreased in the absence of PARP-1
(Supplementary Figure S3c and S3d). Moreover, in MEFs
PARP1 knockout, Bafilomycin A1 recovered LC3 punctated
pattern and LC3II translocation, thereby confirming that
autophagy is an active process which is strongly delayed in
absence of PARP-1 (Supplementary Figure S3c). To further
confirm this result, we treated cells with the potent AMP
mimetic AICAR, which reactivated AMPK (Figure 2f and
Supplementary Figure S3d). Using AICAR in parp-1−/− MEF
cells resulted on restoration of AMPK activity, mTORC1
inactivation and LC3-II lipidation, confirming the data obtained
in starved parp-1−/− MEF cells co-treated with Bafilomycin A1
(Figure 2f and Supplementary Figure S3c). Starved parp-1−/−
MEFs co-treatedwith AICAR, showed an important increase in
the levels of autophagy similar to starved parp-1+/+ MEFs
(Figure 2f). After restoring PARP-1 in parp-1−/− MEF cells we
obtained similar levels of starvation-induced autophagy as in
PARP-1 wild type cells (Figure 2g). All these data suggest that
the presence and proper function of PARP-1 was needed for
the adequate activation of AMPKα and for starvation-induced
autophagy.
Activation of nuclear and cytosolic AMPK requires
PARylation-dependent dissociation of the PARP-1/AMPK
complex from PARP-1. We then aimed to investigate
whether PARP-1 interacts with AMPKα and if PARP-1
modifies its kinase activity by PARylation. To this end we
performed co-IP assays at different times after starvation. Co-
IP experiments revealed an interaction between PARP-1 and
AMPKα in fed cells (Figure 3a). After starvation we observed
a gradual and time-dependent dissociation of the PARP-1-
AMPK complex (Figure 3a) with complete dissociation
reached 30 min upon nutrient deprivation. This dissociation,
in turn, allowed AMPKα activation (Figure 3a INPUT),
concomitant with the inactivation of mTORC1 and autophagy
induction shown above (Figure 2). To substantiate this
physical interaction between PARP-1 and AMPKα we
measured the percentage of co-localization in starved
MCF7 GFPLC3 cells observing that diminished to 6% after
30 min of starvation (Figure 3b).
To get more insights about the interaction between
PARP-1 and AMPKα, we mapped the domains of PARP-1
involved in this interaction. PARP-1 was dissected in three
domains cloned with GST fusion protein18 as explained in
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Supplementary Figure S4a. These constructs were expressed
in Cos1 cells and the co-IP of endogenous AMPKα was
analyzed by GST-pulldown. Starvation-induced autophagy
was confirmed to be efficient in Cos1 cells (Supplementary
Figure S4b). The results indicated that AMPKα interacts
efficiently with the catalytic domain of PARP-1 and to a lesser
extent with the ABC and D domains (Figures 3c and d).
Next, we starved COS1 cells co-transfected with both
pcDNA3-FLAG-AMPKα and GST-fused PARP-1 to confirm
that the AMPK/PARP-1 complex dissociated shortly after
starvation (Figure 3d). Indeed, the interaction between
AMPKα and PARP-1 moved-out confirming the endogenous
co-IP in MCF7 GFPLC3 cells (Figure 3a). Finally we analyzed
the role of PARP activity in PARP-1/AMPK complex stability
and found that PJ34 prevented dissociation of the PARP-1/
AMPK complex after starvation (Figure 3e). Together, these
Figure 2 Inhibition of PARylation down-regulates AMPk pathway. (a, b) Effect of PARylation inhibition on ATP levels and AMPk activation. Treatment with PJ34 and PARP-1
silencing (60 nM) strongly delays starvation-induced loss of ATP levels. Right panel shows the efficiency of PARP-1 silencing.*Po0.05, **Po0.01 versus the indicated group in
MCF7 GFPLC3 cells by t-test (a). MCF7 GFPLC3 cells treated with PJ34 (left panel) or silenced for PARP-1 (right panel) during starvation showed down-regulation of AMPk
activation (b). (c) Effect of PAR accumulation on ATP levels. Accumulation of PAR polymer hadn’t effect on starvation-induced loss of ATP in starved MCF7 GFPLC3. The
efficiency of PARG knock-down was previously shown in Figure 1a.**Po0.01 comparing between control and starved MCF7 GFPLC3 cells and øøPo0.01 comparing between
control and starved PARG silenced MCF7 GFPLC3 cells. (d) Activation of AMPk in absence of PARG. The accumulation of PAR polymer in MCF7 GFPLC3 cells increased the
activation of AMPK under nutrient deprivation. (e) AMPK activation is delayed in absence of PARP-1. Cell extracts of parp-1+/+and parp-1-/ -MEFs after different times of
starvation were used to measure the levels of AMPk activation. (f) AICAR reactivated the AMPk/mTORC1/LC3 pathway in absence of PARP-1. Cell extracts from parp-1+/+,
parp-1−/− and parp-1−/− MEFs pre-treated with AICAR 1 mM were used to measure the levels of AMPk activation (phospho-AMPK), mTORC1 activation (phospho-p70S6k) and
autophagy induction (endogenous LC3-II translocation). (g) Starvation-induced autophagy is increased in parp-1−/−MEFS after AICAR treatment or PARP-1 reconstitution.
*Po0.05, **Po0.01 versus the indicated group by t-test. In B, D, E and F figures total AMPk and total p70s6 kinase were used to normalize for the non-phosphorylated protein
and β-actin or GAPDH were used as loading control. Similar results were obtained in three independent experiments
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results suggest that PARylation of AMPKα takes place after
PARP activation and is needed to disrupt the PARP-1/AMPK
complex, allowing the activation of AMPKα and thereby,
induction of autophagy (Figure 3e).
To demonstrate PARylation of AMPKα during starvation-
induced autophagy, we immunoprecipitated PAR in shPARG
HeLa cells. We found that AMPKα was PARylated at 15
and 30 min of starvation corresponding with the disruption
of the PARP-1/AMPKα complex (Figure 3f). 15 min of nutrient
deprivation induced PARylation of AMPKα, at 60 min
PARylation of AMPKα completely vanished, but at 30 min of
starvation we observed that the levels of PAR associated with
AMPKα were critical to induce phosphorylation of AMPK,
inactivation of mTORC1 and translocation of LC3-II (Figure 3f
and Figure 2). PARP inhibition prevented AMPK PARylation
during starvation and was co-incident with stabilization of
PARP-1/AMPK complex (Figure 3g). To evaluate the possibi-
lity of amutual interaction between AMPK and PARP-1 leading
to PARP-1 phosphorylation, as has been described before,19
we treated the cells with the AMPK inhibitor Compound
Figure 3 Activation of AMPkα requires interaction with PARP-1 and its PARylation. (a) Endogenous co-Immunoprecipitation of AMPkα1 and PARP-1. MCF7 GFPLC3 cells
were starved with HANK buffer for 15, 30 and 60 min. INPUT shows total levels of AMPk, PARP-1 and the activation of AMPk. (b) Confocal microscopy to detect colocalization
between PARP-1 and AMPkα1. MCF7 GFPLC3 cells were starved with HANK buffer for 15 and 30 min. Colocalization percentages were obtained, using a LEICA LCS SP5
confocal microscope. The bar chart shows the percentage of cells in which colocalization foci were observed at control or upon treatment with HANK buffer.*Po0.05 comparing
between control MCF7 GFPLC3 and starved MCF7 GFPLC3 cells by t-test. (c) Interaction by GST-pulldown assay of AMPkα1 protein with PARP-1 catalytic domain. COS1 cells
were co-transfected with FLAG-AMPkα1 and pBC plasmids that over expressed different domains of PARP-1: pBC-ABC (Zn fingers), pBC-D (Automodification domain), pBC-EF
(catalytic domain) and PARP-1 full protein. INPUT shows total levels of AMPkα. (d) Interaction between AMPkα1 and PARP-1 full protein or catalytic domain disappears during
starvation. COS1 co-transfected with FLAG-AMPkα1 and pBC-empty, pBC-PARP-1 full and pBC-EF were starved for 15, 30 and 60 min with HANK buffer. (e) Disruption of
AMPkα1/PARP-1 complex during starvation depends on PARylation levels. COS1 co-transfected with FLAG-AMPkα1 and pBC-empty, pBC-PARP-1 full and pBC-EF were pre-
treated with KU0058948 100 nM 2 h before starved. (f) AMPkα1 is PARylated during starvation-induced autophagy. Immunoprecipitation of PAR polymer in HeLa shPARG
transfected with FLAG-AMPkα and starved with HANK buffer for 15, 30 and 60 min. FLAG antibody shows levels of expression of FLAG-AMPkα1 in HeLa shPARG cells. INPUT
shows starvation-induced PARylation. (g) KU0058948 blocked AMPkα1 PARylation during starvation. HeLashPARG transfected with FLAG-AMPkα1 were pretreated with
100 nM KU0058948 for 2 h and starved for 30 min with HANK buffer. PAR antibody reveals general starvation-induced PARylation and PAR-AMPkα modified protein. (h) AMPK
inhibition using Compound C prevented AMPKα PARylation. HeLa shPARG were transfected with FLAG-AMPkα1. Cells were pretreated with 10 μM Compound C for 4 h and
starved for 30 min with HANK Buffer. INPUT shows total AMPkα. Anti-PAR antibody reveals general starvation-induced PARylation and PAR-modified protein. In all cases, similar
results were obtained in at least three independent assays
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C which indeed prevented AMPK activation and decreased
PARylation associated to AMPK (Figure 3h) suggesting that
full AMPK activity was needed for PARP activation. Taken
together, these data suggest that PARP-1 activation during
starvation signals PARP-1/AMPK complex dissociation, to
activate AMPKα in a PARylation-dependent manner.
To strengthen the previous findings we generated different
mutants of AMPK deficient for Poly(ADP-ribosyl)ation putative
sites (Figure 4a). Expression of mutated proteins, followed by
coIP with the anti-PAR antibody confirmed that AMPK mutants
(AMPKPARdef) were indeed PARylation deficient in the following
order: 1424443 (Figure 4b and Supplementary Fig. S5a).
The most important residues were K291 and E292 whose
change to A almost completely abolished AMPK PARylation
(Figure 4b). We also verified that AMPKPARdef1 interacted with
PARP-1 under basal (non starved) situation. By GST-pulldown
assay in Cos1 cells we confirmed that the AMPKPARdef1 formed
a stable complex with the full protein and the catalytic domain of
PARP-1 under optimal nutrient conditions (Figures 4c and d).
After PARP inhibition and in AMPKPARdef1 this interaction
remained in starved cells (Figure 4c). The interaction between
AMPKPARdef1 and PARP-1 took place in the domains EF of
PARP-1 and after PARP inhibition the complex increased under
nutrient-rich conditions (Figure 4d).
All these data suggest that PARP-1 and AMPK form a stable
complex under rich energy situation. The correct activation of
PARP-1 and the modification by PAR of AMPKα are essential
events in the disruption of the complex to induce total
activation of AMPK under nutrients poor status.
PARylation and nuclear export of AMPKα. Autophagy is a
predominantly cytosolic pathway; thus we hypothesized that
AMPKα modified by PAR (PAR-AMPK) would be exported
from the nucleus to the cytosol to regulate the initial steps of
Figure 4 Specific PARylation of AMPkα1 during starvation-induced autophagy. (a) Putative PARylation sites in AMPKα1 subunit. Comparing with the Sus scrofa and
Xenopus laevis AMPKα1 subunit sequence, human AMPkα1 subunit was specifically mutated in the PARylated putative position E 315, 316 and 317, K 310 and K 305 and E 306,
generating 4 different mutants (AMPKPARdef1, 2, 3, 4). Finally the mutants were tagged with FLAG oligopeptide and subcloned in pCDNA3 plasmid, obtaining two specific vector
pCDNA3-FLAG-AMPkα wt and pCDNA3-FLAG-AMPkα mut. Each mutant represents the following changes: PARdef1: The residues K305,E306,K310,E315,E316,E317 were
mutated in A: PARdef2: The residues K305,E306 were mutated in A: PARdef3: The residues E315,E316,E317 were mutated in A: PARdef4: The residues K310 was mutated in A.
(b) AMPKPARdef blocked AMPkα PARylation during starvation. MCF7 cells were transfected with either FLAG-AMPkα wildtype or AMPKPARdef1,2,3,4 plasmids. INPUT shows total
levels of AMPK. PAR antibody reveals starvation-induced PARylation of AMPKα is disrupted when PARylated putative sites are mutated (AMPKPARdef1,2,3,4). (c) PARP inhibition or
mutation in putative PARylation sites of AMPkα1 prevents the disruption of PARP1/AMPkα1 complex during starvation. COS1 cells were pre-treated with 100 nM KU0058948 for
2 h, or co-transfected with FLAG-AMPkα1 wildtype/mutant protein and pBC-empty/pBC-PARP-1 full protein. Cells were starved for 30 min with HANK buffer. GSTantibody shows
the interaction PARP-1/AMPkα1 in basal and starved situations. (d) AMPkα1 mutated in PARylation sites interacts with PARP-1 in basal conditions. Interaction by GST-pulldown in
COS1 cells co-transfected with FLAG-AMPkα1 wildtype and mutant isoforms and pBC PARP-1 or pBC EF plasmids that over expressed full protein and the catalytic domain of
PARP-1. Transfected COS1 cells were pretreated with 100 nM KU0058948 for 2 h. In B, C, D figures similar results were obtained in three independent assays
Post-translational modiﬁcation of AMPK by PARylation
JM Rodríguez-Vargas et al
6
Cell Death and Differentiation
starvation-induced autophagy. To determine if PARylation of
AMPKα induced cytosolic AMPK activation during autophagy,
we measured the levels of total and activated AMPKα in
nuclear and cytosolic fractions during starvation–induced auto-
phagy. Sub-fractionation assays showed that nuclear AMPKα
declined at 30 min of starvation. Nuclear export of AMPKα was
co-incident in time with activation of cytosolic AMPKα
(Figure 5a Left Panel). Silencing of PARP-1 prevented AMPKα
vanishing from the nucleus and the cytosolic activation of
AMPKα (Figure 5a Left Panel). To confirm this result we
treated cells with PARP inhibitors which retained AMPKα in the
nucleus and abolished the activation of AMPKα in cytosol after
starvation (Figure 5a Central and Right Panels). The carrier
protein Crm1 is involved in the nuclear export of a large
number of proteins and is efficiently inhibited by Leptomycin B.
To confirm the impact of the nuclear-cytosolic export of
PAR-AMPKα in autophagy, we used Leptomycin B which led
to nuclear accumulation of AMPKα. Moreover, the activation of
AMPKα after 30 min of starvation declined after Leptomycin B
treatment (Figure 5b). The levels of autophagic cells (and
autophagosomes per cell) at 30 min of starvation decreased
with Leptomycin B compared to untreated starved (Figure 5c).
Finally we demonstrated that AMPK PARylation was
necessary to induce its nuclear export during starvation using
the AMPKPARdef mutants which were unable to undergo
nuclear export, similar to the results obtained after PARP
inhibition (Figure 5d). The presence of AMPKPARdef abrogated
the activation of AMPK in cytosol (Figure 5d) and totally
inhibited the induction of autophagy (Figure 5e).
Inhibition of PARylation prevents mTORC1 down-
regulation and ULK1 activation during autophagy. Once
activated by falling energy status, AMPK switches-on ATP-
producing catabolic pathways such as autophagy. Under
nutrient-rich conditions mTORC1 interacts with ULK1 com-
plex inactivating the autophagosome formation. However,
during starvation the energy depletion induces AMPK
activation and mTORC1 inactivation.
We asked for the consequences of PAR-AMPKα nuclear
export on ULK1 activation. First we analyzed the interaction
AMPKα/ULK1 during starvation and the effect of PARP
inhibitors. Co-IP and co-localization assays in MCF7 cells,
showed that after 30 min of starvation AMPKα interacted with
ULK1, confirming the sequence of events from activation/
PARylation and nuclear export of AMPKα after starvation
(Figures 6a and b). Starvation during 30 min was sufficient to
Figure 5 PARylation and nuclear export of AMPk. (a) Nuclear export of AMPk during starvation. The nuclear and cytosolic fractions were prepared from fed or starved MCF7-
GFPLC3 cells, co-treated or not with PJ34 (10 μM) or KU0058948 (100 nM) or silenced for PARP-1. PJ34 and KU0058948 were used as pre-treatment during 2 h and maintained
during starvation assay. (b) Leptomycin B prevents nuclear export of AMPkα1 during starvation. MCF7-GFPLC3 were pre-treated with Leptomycin B 20 ng/ml during 3 h and
maintained during starvation with HANK buffer for 30 min. (c) Effect of Leptomycin B, PJ34 and KU0058948 on autophagy levels. MCF7 GFPLC3 cells were co-treated with
20 ng/ml Leptomycin B, 10 μMPJ34 or 100 nM KU0058948 and starved with HANK Buffer 30 min. Cells with the typical punctated pattern of starvation-induced LC3 was counted
by fluorescence microscopy. Similar results were obtained in three independent experiments. At least 250 cells were counted in a Zeiss fluorescent microscope in 3 independent
experiments. **Po0.01 versus the indicated group by t-test. (d) Nuclear export of AMPk during starvation is blocked by PARylation sites mutation in AMPkα1. MCF7 GFPLC3
cells were transfected with FLAG-AMPkα1 wildtype and AMPKPARdef mutants. (e)Mutation in PARylated sites of AMPkα1 blocks autophagy induction. MCF7 cells transfected with
FLAG-AMPkα1 wildtype and mutants (PARdef 1-4), and starved for 30 min. Autophagy induction was assessed by specific endogenous LC3-II translocation. Similar results were
obtained in three independent experiments. In A, B and D figures, total levels and activation of AMPk (Phospho-AMPk) were analyzed in both fractions.
α-tubulin and PARP-1 and/or Lamin B1 were used as cytosolic and nuclear fractions respectively. Similar results were obtained in three independent experiments
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provoke activation of ULK1, total inhibition of mTORC1 and
endogenous LC3-II translocation (Figure 6b). Interestingly
PARP inhibition disabled the interaction AMPKα/ULK1 during
starvation, as the percentage of endogenous co-localization of
both proteins decreased in starved cells treated with PARPi
(Figure 6c). We have demonstrated that PAR-AMPK shuttled
from nucleus to cytosol during starvation and interacted with
ULK1 to promote its proper activation favouring the initial steps
in the autophagosomes formation. Immunoprecipitation of
AMPK in presence of the PARP inhibitor Ku0058948
demonstrated that PARylated-AMPK formed a stable complex
with ULK1 protein (Figure 6d). But, was this modification
needed to maintain AMPK/ULK1 complex? To address this
question we measured the activation of ULK1 following
starvation in the presence of PARP inhibitors and we found
that PARPi prevented ULK1 phosphorylation (Figure 6e).
Consistently, PARP1 knockdown in starved MCF7 GFPLC3
cells impeded ULK1 (as well as Raptor) phosphorylation,
Figure 6 PARP inhibitors and PARP-1 silencing modulate ULK1 activation. (a, b) Interaction AMPk/ULK1 during starvation. MCF7 GFPLC3 cells were starved with HANK
Buffer for 15, 30 and 60 min. INPUT shows total levels of AMPk and ULK1 (a). Different times of starvation were used to measure the levels of ULK1 activation (phospho-ULK1),
mTORC1 inactivation (phospho-p70S6k) and autophagy induction (endogenous LC3-II translocation) (b). (c, d) Effect of PARylation inhibition on AMPk/ULK1 interaction. MCF7
cells were starved with HANK Buffer for 30 min and co treated with PJ34 10 μM. Colocalization percentages were obtained quantifying the Immunofluorescence from the z-stacks
on every imagein a LEICA LCS SP5 confocal microscope. The histogram shows the percentage of cells in which colocalization foci were observed. **Po0.01 versus the
indicated group by t-test (c). Immunoprecipitation of AMPK in HeLa shPARG transfected with FLAG-AMPkα wildtype. Cells were starved with HANK Buffer for 30 min. 90 min pre-
treatment with 100 nM KU0058948 was maintained during starvation. FLAG antibody shows levels of expression of FLAG-AMPkα1 and the specific PARylation of AMPkα1 in
HeLa shPARG cells. ULK1 antibody shows AMPkα1/ULK1 interaction is prevented by PARP inhibition. INPUT shows starvation-induced PARylation (d). (e) Effect of PARP
inhibitors on ULK1 activation. MCF7 GFPLC3 cells were starved with HANK Buffer for 15, 30 and 60 min. Total ULK1 kinase was used to normalize for the non-phosphorylated
protein. (f) Silencing of PARP-1 down-regulated ULK1 activation (left panel) and maintained mTORC1 activation during starvation-induced autophagy (right panel). MCF7
GFPLC3 cells were transfected with PARP-1 siRNA (60 nM). scrambled or non-specific siRNA was used as negative control, using the same protocol as for siRNA transfection.
48 h later were starved with HANK Buffer for 15, 30 and 60 min. In A, C, E and F figures total ULK1, p70s6 and Raptor kinase were used to normalize for the non-phosphorylated
protein. α-tubulin and β–actin were used as loading control. Similar results were obtained in three independent experiments
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leading to the recovery of mTORC1 activity and the inhibition
of autophagy (Figure 6f).
All these data suggest that PARylation is a crucial PTM on
AMPK to induce an optimal activation and loading of ULK1
complex eventually leading to induce autophagosomes
formation.
Discussion
Autophagy is regulated by a highly interconnected arrangement
of proteins are involved in the control of key cellular processes.
Autophagic responses in conditions of nutrient deprivation
serve metabolic purposes and various intracellular entities can
be degraded to provide the cell with metabolic substrates for
survival. In response to nutrient deprivation AMPK is activated
upon the accumulation of AMP at the expense of ATP. Multiple
signal transduction pathways that ultimately accelerate or
inhibit the autophagic flux do so by impacting on the activation
state of AMPK and/or mTORC1.16,20
AMPK functions as a fuel gauge and maintains energy
homeostasis during cellular stress21 and is activated by
changes in the cellular AMP:ATP and ADP:ATP ratios. AMPK
functions to restore energy homeostasis by switching-off
biosynthetic pathways consuming ATP while switching-on
catabolic pathways that produce ATP. Upstream kinases
phosphorylate the critical Thr172 activating site and include
liver kinase B1 (LKB1), calcium–calmodulin-dependent
kinase kinase 2 (CaMKK2) and transforming growth factor-β-
activated protein kinase-1 (TAK1).22 PTM regulation of
autophagy has been extensively reported and mechanisms
including phosphorylation, glycosylation, ubiquitination, acet-
ylation and lipidation have been shown to be critical in the
ability of ATGs and other autophagy-related proteins to
interact with regulators of this route.23
In the present study we demonstrate that the modification of
AMPK by PARylation and the mutual interaction between
PARP-1 and AMPK function as a multifaceted molecular
switch to optimize the initiation of autophagy summarized in
Figure 7: (1) non-PARylated nuclear AMPK is inactive when in
complex with PARP-1 in non-starved cells; (2) following
starvation PARP-1 is activated and AMPK is transiently
PARylated and detached from PARP-1; (3) complex dissocia-
tion and AMPK PARylation trigger kinase activation which is
needed to undergo AMPK nuclear export and activation of the
cytosolic AMPK pool.
Interaction between PARP-1 and AMPK has been pre-
viously shown to be needed for DNA-damage dependent
PARP-1 activation and PARP-1 has been reported to be a
substrate of AMPK.19,24 The molecular insights for this mutual
interaction still remain to be fully elucidated. Our results
suggest that AMPK activation is hindered by its interaction with
PARP-1 that most likely will be in turn phosphorylated by
AMPK following starvation. Indeed, both global and AMPK-
associated PARylation are decreased in the presence of
the AMPK inhibitor compound C (Figure 4e). DNA binding
domain of PARP-1 has been reported to be phosphorylated by
AMPK at Ser-177 leading to PARP-1 dissociation from
Bcl-6 promoter.24 Given the highly elaborated nature of the
autophagic pathway, the mutual regulation of AMPK and
PARP-1 is likely to be complex and future studies are required
to have a comprehensive understanding of this crosstalk in
response to the wide range of autophagy-inducing signals.
One of the most remarkable finding in this study is the need
of AMPK nuclear export to perform its cytosolic function during
the induction of starvation-induced autophagy but how
PARylated AMPK coming out of the nucleus ‘hits’ cytosolic
AMPK remains to be clarified. The nucleus has been
implicated in the initiation of autophagy as a primary site of
conditions that are potentially toxic for mammalian cells, as
they cause DNA damage or perturb/prevent proper DNA
replication.25 Nuclear sensors, including PARP-1, detect
perturbations in nuclear and genetic homeostasis, to activate
mechanisms for the repair of cellular damage and, if these fail,
trigger different types of cell death for the benefit of organismal
homeostasis. Increasing evidences indicate that repair of DNA
lesions activate a non-selective autophagic response.26 The
fine-tuning of key biological processes, other than DNA repair,
through PARylation is still largely unknown. Our study provides
new implications of PARylation as a dynamic process in
autophagy beyond PARP-1 activation and its association with
DNA repair and energy balance, as has been reported
previously.7,27 Our results place the nucleus and the interac-
tion between PARP-1 and AMPK as an initial sensor of the
metabolic alterations derived from perturbations in the
nutritional extracellular status not necessarily related with
the alterations in genomic integrity.
PARylation as a PTM process may also be involved in the
regulation of more downstream autophagy events. Our results
show that activation of ULK1/inactivation of mTOR might also
be modulated by PARylation, although the precise substrates
have not been defined. PARylation has also been recently
implicated as regulatory signal for proteasomal-mediated
protein degradation.28 In summary, our study supports a model
where PARP activation and PAR levels during starvation-
induced autophagy leads to global modulation of autophagic
fluctuations and more specifically induce de-repression of
AMPK activity (Figure 7). Until now, nuclear events have not
been considered to be of critical importance for autophagy. Our
data, however, uncover an essential connection between the
induction of autophagy and AMPK PARylation which deter-
mines its export out of the nucleus to unleash the early cytosolic
events of autophagy, including inhibition of mTORC1 and de-
repression of ULK1-kinase (Figure 7b). Previous results have
shown that in cytoplasts/enucleated cells the autophagic
process is still feasible.29 Our findings do not contradict the
previous conclusions about functionality of the autophagic
process in enucleated cells, but add a new early regulatory axis
influencing the outcome of autophagy. The discovery of tightly
regulated PAR-modified proteins associated with the autopha-
gic process offers a striking conceptual context to understand
the short-term response to stimuli eliciting autophagy. Partici-
pation of nuclear AMPK in autophagy is needed to convey a
rapid response of the alteration in the metabolic status,
indicated by the level of PARylation as an alert indicator of
changes in the energy balance. Cells deficient in PARP-1 are
still able to undergo starvation-induced autophagy but the
outcome of this delay may imply important consequences for
the time-frame of drug treatment and the sensitization of tumor
cell in their microenvironment to different combinatorial regimes
including PARP inhibitors.
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Materials and Methods
Cell cultures and treatments. MCF7 GFP-LC3 cells were cultured in RPMI
1640 GlutaMAX (GIBCO Invitrogen) with 6% inactive fetal bovine serum (FBSi,
Gibco Invitrogen) and Pen/Strep (P4333, Sigma-Aldrich, St Louis, MO, USA).
Immortalized mouse embryonic fibroblast (MEFs 3T3), derived from both wild-type
and PARP-1 KO mice, cell lines were cultured in Dulbeco’s Modified Eagle’s Medium
(DMEM) supplemented with 10% FBSi. ShVector and shPARG A549 cell lines were
cultured in DMEM supplemented with 10% FBSi, L-Glutamine 2 mM, Pen/Strep and
5 μg/ml Puromycin and selection antibiotic. ShVector and shPARGHeLa cells were
cultured in DMEM supplemented with 10% FBSi, Gentamicin 50 ng/ml and
Hygromycin B 1:400 as antibiotic selection. All cell lines were maintained at 37 °C in
a humidified 5% CO2 atmosphere. Cells were starved with Balanced HANK Buffer
without Aminoacids (140 mMNaCl, 5 mM KCl, 1.3 mM MgCl2-6H2O, 2 mM CaCl2-2
H2O, HEPES 10 mM, 5 mM D-Glucose), at different times as stated in the figures.
Cells were treated with the PARP inhibitors PJ34 ([N-(6-Oxo-5,6-dihydro-
phenanthridin-2-yl)-N,N-dimethylacetamide]), DPQ (3,4-Dihydro-5-[4-(1-piperidinyl)
butoxy]-1(2H)-isoquinolinone]) (Alexis Biochemicals, San Diego, CA),Olaparib
(KU0059436, Selleckchem) and KU0058948 (KU0058948, supplied from Francoise
Dantzer’s Lab). DPQ and Olaparib were dissolved in DMSO while KU0058948 and
PJ34 were dissolved in miliQ H2O2 and stored at -20 ºC. For treatments, cell were
pre-treated with 40 μM DPQ, 10 μM PJ34, 100 nM KU0058948 and 10 μM Olaparib
for 1.5 h before starvation and maintained all the time of the experiments.
The autophagy inductors Rapamycin (553210 Calbiochem, Germany) and
Concanamycin A (C9705 Sigma-Aldrich) were dissolved in DMSO at 1 mM (Rapa)
and 100 nM (Con A) and stored at -20 ºC. Autophagy inhibitors 3-Methyladenine
(M9281Sigma-Aldrich), Chloroquine (C6628 Sigma-Aldrich) and Bafilomycin
A1 (B1793 Sigma-Aldrich) were dissolved in PBS1x (Chloroquine) RPMI 1640
(3-MA) and DMSO (Baf A1) and maintained at -20 ºC. For treatments, cell were
pre-treated with 5 mM 3-MA, 10 μM CQ, 0.2 μM Baf A1, 100 nM Rapa and 4 nM
Con A for 1.5 h before starvation and maintained all the time of the experiment.
The mimetic of AMP, AICAR (5-Aminoimidazole-4-carboxamide 1-β-D-ribofurano-
side, Acadesine, N-(β-D-Ribofuranosyl)-5-aminoimidazole-4-carboxamide, A9978,
Sigma-Aldrich) was dissolved in H2O:47 mg/ml and stored at − 20 ºC. Compound
C (P5499 Sigma-Aldrich) AMPK inhibitor, was dissolved in DMSO at 4 mg/ml and
maintained at -20 ºC. For treatments, cell were pre-treated with 1 mM AICAR for 1.5 h
and 10 μM 4 h before starvation and maintained all the time of the experiment.
Nuclear export inhibitor Leptomycin B (L6417 Sigma-Aldrich) was dissolved in
methanol:water (7:3) and maintained at -20 ºC; was used in a final concentration
20 ng/ml during 3 h.
Western blot analysis. Cell lines were plated in 6-well plates with a density of
3 × 105 cells per plate and treated the next day with HANK buffer. After the nutrient
starvation, cells were washed twice with PBS1x, resuspended in 200 μl of Lysis
Buffer TR3 (10 mM Na2HPO4, 10% Glycerol, 20% SDS) and harvested. The
samples were sonicated 10 s at 50% power in ‘constant’ mode. Finally it was added
a pre-heated Blue-β-Mercaptoethanol solution (1:1) 1:10 under the safety hood. All
the samples were maintained at -20 ºC. Proteins were resolved on SDS-10%,
SDS-5% polyacrylamide gels and AmershamTMECLTM Gels 4-12% (28-9898-06 GE
Healthcare, Sweden) and transferred onto PVDF Membrane (Biorad, Berkeley, CA).
The blots were blocked with 5% milk powder in PBS1x with 0.1% Tween-20 for
60 min, washed with PBS1x/Tween, and incubated overnight with the different
antibodies anti-poly(ADP-ribose) (PAR) (20591E10, TREVIGEN, My), anti-PARP-1
Figure 7 PARylation regulates autophagy through AMPK activation:. PARP-1 forms a complex with AMPK in nucleus (1). During the starvation-induced autophagy ROS
production induces DNA damage and overactivation of PARP-1. Auto PARylated PARP-1 is able to modify by PARylation AMPK in AMPKα1 subunit (2). The complex is disrupted
and PAR-AMPK is exported to cytosol (3). Presence of PAR-AMPK and continuous absence of Aminoacids and ATP depletion, favours total activation of AMPK population,
inhibition of mTORC1, interaction PAR-phospho-AMPK/ULK1 and autophagosomes formation (4). (a). Starvation-induced ROS production was abrogated during the treatment
with PARP inhibitors. Following AMPKα1/PARP-1 interaction (1), AMPKα1 subunit is not PARylated and nuclear export of AMPK is inhibited (2 and 3). In spite of nutrient and
energy depletion, AMPK is inhibited, mTORC1 is partially activated and interacts with ULK1 favouring it’s inhibition (4). Finally the autophagosomes production will be delayed (b)
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(C2-10) (ALX-804-210, Alexis Biochemicals, LA), anti-LC3 (PD014, MBL, NY), anti-
phospho-p70s6 kinase (Thr389) (#9205, Cell Signaling Technology Beverly, MA),
anti-p70s6k (sc-8418, Santa Cruz Biotechnology, Santa Cruz, CA ), anti-phospho-
AMPkα (Thr172) (#2535, Cell signalling Beverly, MA), anti-AMPkα (#2603, Cell
Signaling, Beverly, MA), anti-phospho-ACC (Ser79) (#3661, Cell signalling Beverly,
MA), anti-ATG7 (#2631, Cell signalling Beverly, MA), anti-Beclin1 (612112, BD
Biosciences), anti-phospho-ULK1 (Ser317) (#6887, Cell signalling Beverly, MA),
anti-ULK1 (#4776, Cell signalling Beverly, MA), anti-phospho-Raptor (Ser792)
(#2083, Cell signalling Beverly, MA), anti-Raptor (N-19) (sc-27744, Santa Cruz
Biotechnology, Santa Cruz, CA), LAMP1 (sc-20011 Santa Cruz Biotechnology,
Santa Cruz, CA) α-tubulin (Sigma-Aldrich), β-Actin (Sigma-Aldrich) and GAPDH
(Santa Cruz Biotechnology, Santa Cruz, CA) were used as loading control. Bands
were visualized by ECL-PLUS (Amersham Biosciences) and the pictures were
taken with the imaging system Image Quant LAS 4000 (GE Healthcare)and medical
X-ray films (AGFA).
Immunofluorescence. Immunostaining for poly (ADP-ribose) (PAR) was
performed on cells grown on glass cover-slips (density of 3.5 × 104 cells per well
and in 6-well plates) and fixed with 3% paraformaldehyde, 2% sucrose, PBS1x
solution for 10 min RT. Fixed cells were permeabilized with 0.5% Triton-X100,
PBS1x solution for 5 min RTand blocked with 2% BSA PBS1x for 1 h at 37 ºC. Poly
(ADP-ribose) was detected using monoclonal antibody (PAR) (20591E10,
TREVIGEN, My) 1:600 and cy3-conjugated goat anti-mouse immunoglobulin
(C2181-1 ML, Sigma-Aldrich) 1: 800 in 2% BSA PBS1x solution. Nuclear
counterstaining with DAPI (1:5000 in PBS1x) was performed after removal of
excess secondary antibody. Cells were mounted on microscope slides with
Vectashield mounting medium for fluorescence (H-1000, Vector, CA). Immunostain-
ing was visualized with a Zeiss Fluorescence Microscope.
ATP determination. Cell lines were plated in 6-well plates with a density of
5 × 105 cells per plate. Intracellular ATP was measured using a luciferin/luciferase-
based assay (Adenosine 5’-triphosphate (ATP) Bioluminescent Assay Kit, Sigma-
Aldrich) following manufacturer’s guidelines. A standard curve was generated
rather than known concentrations of ATP and used to calculate sample ATP
concentrations. Protein concentration was determined using Bradford protein assay
reagents (Bio-Rad). The content of ATP was normalized for protein content and
expressed as percentage of control.
Autophagy assays. GFP-LC3-expressing cells have been used to demon-
strate induction of autophagy. We used MCF7 cells expressing stably GFPLC3 and
the transitory GFP-LC3 expression vector, kindly supplied by Dr. T. Yoshimori,
(National Institute for Basic Biology, Okazaki, Japan), in parp-1+/+ and parp-1−/−
MEFs cells transiently transfected with this vector with jetPEITM (Polyplus
Transfection, Illkirch, France), according to the manufacturer’s protocol. The assay
was performed on cells grown on glass cover-slips (4 × 104 cells per well) in
6-well plates and after the different treatment with HANK buffer, these cells were
washed 3 times with sterile PBS1x and fixed with Paraformaldehyde Solution
(4%, wt/vol in PBS1x with 2% Sucrose) for 10 min at room temperature. To
determine LC3 localization GFP-LC3-transfected cells were observed under
a Zeiss Fluorescence Microscope and to determine the endogenous LC3-II
translocation in MCF7 GFPLC3, parp-1+/+ and parp-1−/−MEFs cells, we performed
a western blot of LC3-I and its proteolytic derivative LC3-II (18 and 16 KDa,
respectively), using a monoclonal antibody against LC3, from MBL (PD014,
MBL, NY). Rapamycin and Concanamycin A were used as autophagy inductors,
positive controls.
RNA interference. These assays were performed on cells grown on glass
cover-slips (6 × 104 cells per well) in 6-well plates for fluorescence microscopy and
9 × 104 cells in 6-well plates for western blot assays in RPMI 1640 GlutaMAX
(GIBCO Invitrogen) with 6% FBSi without antibiotic. Cells were transfected with the
indicated siRNAs at 50 nM (iBclin1 and iATG7), 60 nM (iPARP-1 and iULK1), 30 nM
(iPARG and iLAMP1) using LipofectamineTMreagent (Invitrogen) or JetPrime
reagent (Polyplus Transfection, Illkirch, France), according to the manufacturer’s
guide. SiRNA corresponding to the cDNA sequences were: ATG7, ULK1 from
Sigma, Human PARP-1 from Ambion Applied Biosystems and Beclin1, PARG and
LAMP1 from Santa Cruz Biotechnology. After 48 h after of transfection, cells were
treated as described and observed under a Zeiss Fluorescence Microscope or the
proteins were extracted.
Cell viability assay. MCF7 GFPLC3 cells were seeded in 24-well plates with a
density of 1.2 × 104 cells per well, with different treatments with HANK buffer. The
levels of cell viability were determined using MTT Cell Proliferation Kit I (1-65-007,
Roche, Mh, Germany). MTT assay (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyl
Tetrazolium Bromide, ) was performed following manufacturer’s instructions.
Co-Immunoprecipitation. MCF7 GFPLC3 cells were plated in p100 plates
with a density of 1 × 106 cells per plate. After starvation, cells were washed 2 times
with PBS1x Pefabloc 0.5 mM, resuspended in 200 μl of Lysis Buffer EBC
(50 mMTris-HCl pH8, 120 mMNaCl, 0.5% NP-40, 1 mM PMSF, Protease Inhibitor
Complete Mini Roche), on ice 30 min, vortex 3 times. Centrifuge 13.000 rpm 20 min
4 °C and obtained the INPUT, the rest of supernatant was incubated with 35 μl of
Protein Sepharose A (PAS) 30 min 4 °C rocking. 13.000 rpm 5 min 4 °C to obtain
the Pre-Immune (PI) supernatant using anti-Cyt C (sc-7159, Santa Cruz
Biotechnology, Santa Cruz, CA) and pellet in 50 μl EBC Buffer with PAS, rocking
1-2 h 4 ºC. Co-IP of AMPk and PARP-1 or AMPk and ULK1 endogenous proteins
performed using AMPk, PARP-1 and ULK1 (1:100) antibodies previously described.
Co-IP was incubated at 4 °C o/n rocking and centrifuged 13.000 rpm 5 min 4 ºC.
Pellets were washed 5 times with 500 μl NET-N buffer per sample (20 mMTris-HCl
pH8, 100 MNaCl, 0.5% NP-40, 1 mM EDTA, 1 mM PMSF, Protease Inhibitor
Complete Mini Roche) 13.000 rpm 4 °C 5 min. Finally the pellet was resuspended
in Loading Buffer 2x and maintained at -20 ºC.
AMPk mutation in PARylation sites. Amino acids which can be
potentially PARylated in AMPK were searched in silico and selected according
to previously described PARylation consensus sequences and in particular the PAR
acceptor aminoacids found for the transcription factor CTCF that were conserved in
AMPKα.30 Mutations of such individual amino acids (K to A or E to A as specified
in Figure 4a) generated 4 mutants (AMPKPARdef1, 2, 3, 4) and Wild Type constructs
were tagged with FLAG oligopeptide and sub-cloned in pCDNA3 expression vector
(pCDNA3-AMPKα1-FLAG). Total structure from AMPk alpha 1 protein was
screened comparing with different putative PARylated motives in different proteins.
Putative PARylation site in AMPK alpha1 subunit (DEALKEVCEKFECSEEEVLS)
was identified comparing with CTCF transcription factor, previously described
as Poly ADP-Ribose acceptor TEEG-KDVDVSVYDFEEEQQ.31 AMPkα deficient
in PARylation1 mutant (AMPKPARdef1) was generated using de novo synthesis
and sub cloning in a XhoI site in pCDNA3 expression vector (pCDNA3-
AMPKalpha1-FLAG).
AMPkα deficient in PARylation mutants 2, 3 and 4 were carried out using the Q5
Site-Directed Mutagenesis Kit (New England Biolabs, Ipswich, MA). A pcDNA3-flag
plasmid carrying the wild type AMPK cds was used as template. Orientation, integrity
and fidelity of all the cloned fragments were checked by Sanger sequencing.Plasmids
were transfected with JetPEI co-transfection according to the manufacturer’s guide.
PARylation assay. ShPARG HeLa cells were plated in p100 plates with a
density of 1 × 106 cells per plate and transfected with JetPEI reagent (Polyplus
Transfection, Illkirch, France) with the plasmid pcDNA3-FLAG-AMPkα containing
the wildtype and mutant forms of AMPk alpha 1 subunit, according to the
manufacturer’s guide. Twenty-four hours later, cells were starved at different times
with HANK Buffer. After starvation, cells were washed 2 times with PBS1x Pefabloc
0.5 mM, resuspended in 500 μl of Lysis Buffer EBC ( 50 mMTris-HCl pH8,
120 mMNaCl, 0.5% NP-40, 1 mM PMSF, 1 mM Na3VO4, 10 mMNaF, Protease
Inhibitor Complete Mini Roche), on ice 20 min. Centrifuge 13.000 rpm 20 min 4 °C
and obtained the INPUT, the rest of supernatant was incubated with 35 μl of Protein
Sepharose A (PAS) 1 hour 4 °C rocking. IP of endogenous PAR polymer performed
using PAR (1:50) polyclonal antibody (4336-APC-050, TREVIGEN, My). IP was
incubated at 4 °C o/n rocking and centrifuged 13.000 rpm 5 min 4 ºC. Pellets were
washed 4 times with 500 μl of EBC 250-120 mMNaCl. Finally the pellet was
resuspended in Loading Buffer 2x and maintained at -20 ºC.
GST-Pulldown. COS1 cells were seeded (1 × 106) on p100 plates and
transfected with JetPEITM co-transfection (Polyplus Transfection, Illkirch, France) with
the plasmids expressing FLAG-AMPkαwildtype and mutant, GST-PARP-1 full fusion
proteins and ABC, D and EF PARP-1 domains and GST fusion protein as transfection
control; according to the manufacturer’s guide. Forty-eight hours later, cells were washed
with PBS1x Pefabloc and lysed in B buffer (20 nMTris-HCl (pH 7.5), 400 mMNaCl, 20%
glycerol, 5 mM DTT, 0.5 mMPefabloc,NP40 0.5%, protease inhibitors (Complete Mini;
Roche, Mannheim, Germany)). Lysates were cleared by centrifugation (10.000 rpm
15 min 4 ºC) and incubated for 2 h with glutathione-Sepharose 4B (Amersham). Beads
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were washed 3 times with DB buffer (200 mMTris-HCl (pH 7.5), 150 to 500 nMNaCl,
0.1% NP-40, and protease inhibitors). All samples were resuspended in charge buffer,
boiled for 5 min and analysed western blot. Blots were subsequently incubated with anti-
GST antibody (A190-121A, Bethyl Lab, Mt, Texas) and anti-FLAG (F3175 Clone M2,
Sigma-Aldrich).
Confocal microscopy co-localization. MCF7 cells were grown on cover-
slips (density 4.5 × 103) and starved at different times. Cells were fixed with 3%
paraformaldehyde, 2% sucrose, PBS1x solution for 10 min RT. Fixed cells were
permeabilized with 0.5% Triton-X100, PBS1x solution for 5 min RTand blocked with
2% BSA PBS1x for 1 hour at 37 ºC. Incubation with primary antibodies anti-
AMPkand anti-PARP-1 were performed in 2% BSA PBS1x for 30 min at 37 ºC, and
second antibodies (FITC labelled anti-mouse, Cy3 labelled anti-rabbit IgG, both
from SIGMA) in 2% BSA PBS1x for 20 min at 37 ºC. After extensive washing with
PBS1x, coverslips were mounted with Vectashield mounting medium. Images were
captured on a Leica LCS SP5 confocal microscope. Colocalization percentages
were quantifying the immunofluorescence obtained from the z-stacks on every
image. The bar chart shows the percentage of cells in which colocalization foci were
observed at control or upon treatment with HANK buffer. *Po0.05.
Subfractionation cytosol nucleus. MCF7 GFPLC3 cells were seeded in
p100 plates (density 1 × 106) and starved at different times. To obtain the nuclear
and cytosolic fraction, cells were washed 2 times with PBS1x and lysed with 300 μl
of Buffer A (0.5 M Hepes-KOH pH7.8, 1 M MgCl2, 1 M KCl, 1M DTT). Cells in
eppendorfs were gently pipetting up and down 10 times and were incubated in ice
10 min. All samples were mixed with 10% TritonX-100 (vortex 30 s) and were
precipitated 11.000 rpm 4 °C during 1 min. Take off the supernatant (Cytosolic
Extract CE) and the pellet (Nuclear Extract NE). The NE fraction was washed with
100 μl of Buffer A 11.000 rpm 4 °C 1 min. NE extracts were mixed with 1/5 vol of
Buffer C (0.5 M Hepes pH7.8, Glycerol, 5 M NaCl, 1 M MgCl2, 0.25 M EDTA, 1 M
DTT) and CE extracts with 1/10 vol of Buffer B (0.5 M Hepes pH7.8, 1 M KCl, 1 M
MgCl2). Finally all the samples were precipitated 15.000 g 4 °C 15 min. All the
supernatants were mixed with loading buffer and maintained at -20 ºC.
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